KCNN3 and atrial fibrillation: Moreover, blocking KCa2.3 channels could be of potential benefit in the treatment of supraventricular arrhythmias, e.g., atrial fibrillation as shown in rats and dogs (Diness et al., 2011; Qi et al., 2014).